Return to Article Details
TREATMENT RESULTS OF R-GEMOX REGIMEN IN RELAPSED/REFRACTORY B CELL LYMPHOMA WITHOUT HIGH-DOSE CHEMOTHERAPY INDICATIONS AT THE K HOSPITAL 2019-2022
Download
Download PDF